Kjmjones Posted July 16, 2022 Share Posted July 16, 2022 After remaining NED for 15 months post surgery/chemo and radiation for stage III nsclc my oncologist recommended a Signatera test. The first test came back negative for MRD (Molecular Residual Disease) but the second test was positive(0.8%) The next step involves testing for any mutations and the possible use of targeted therapy. Is there a standard protocol for treating MRD? Any advice or personal experience would be appreciated. Link to comment Share on other sites More sharing options...
Judy M2 Posted July 16, 2022 Share Posted July 16, 2022 Testing for a mutation is the right move. From my very limited understanding of MRD, a targetable mutation is what would be treated. Link to comment Share on other sites More sharing options...
Kjmjones Posted July 17, 2022 Author Share Posted July 17, 2022 Thanks for your reply Judy! Do you know anyone who has tested with Signatera? Link to comment Share on other sites More sharing options...
Judy M2 Posted July 17, 2022 Share Posted July 17, 2022 No, I've never even heard of Signatera. Link to comment Share on other sites More sharing options...
Karen_L Posted July 18, 2022 Share Posted July 18, 2022 Kjmjones, where are you receiving treatment? Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.